Telix opens radiopharmaceutical facility in Australia for cancer treatment
The facility aims to address manufacturing capacity challenges and bring production and patient administration closer together.
Drug Development
Harbour BioMed and Kelun-Biotech receive China IND approval for asthma therapy
FDA grants priority review to Roche’s Gazyva/Gazyvaro for pMN
Innovent licenses IBI355 rights to Spero for up to $1.1bn
Novartis and Chai Discovery collaborate on antibody identification
Cellares and Sonoma partner to automate cell therapy manufacturing
Takeda and Indonesia partner on plasma-derived therapies
FDA approves MSD’s Keytruda combinations for MIBC
